Innovative SMEs are likely to go into exile
Posted by adminHunting tax loopholes while declaring his intention to encourage innovation is a difficult exercise. Measures Bill 2011 Finance defended by MPs and the government caused the anger of several professional associations.
France Biotech, CroissancePlus the Richelieu Committee, Entrepreneurship, MEDEF, the union's national game, the French association of software publishers, Leem, the association of pharmaceutical companies and the cluster Cap Digital denounce threats against the 2200 start-ups and SMEs with the status of "young innovative company."
This status allows an SME under the age of eight years of being exempt payroll for eight years on the salaries of its employees who participate in research projects.
"I am surprised and shocked by the planned reform.The government renders meaningless the status of the young innovative company when it was created only six years ago and is effective. There have been no changes as a start-up innovation in a market such as biotechnology and new energy needs 8 to 12 years to launch its products on the market, "said Philippe Pouletty, honorary president of France Biotech. The reform of regulations and measures passed by MPs that reduce the research tax credit "will increase to January 1 of 30-40% the cost of payroll researchers from innovative start-ups. If such measures were applied to restaurants or cafes at France Telecom, it would be a revolution, "says Philippe Pouletty.
In Bordeaux, the founders of the start-up specializing in Internet Libcast employs 8 people, looking for a parade. "This decision requires us to serious adjustments.We need to revise our business plan and strategy but not thoroughly, "says Sandrine Mayoux, one of three partners. The young company that seeks 300,000 euros in turnover this year, could go live in London. "The British Embassy in Paris contacted us. The English want to attract small innovative companies like ours, "says Sandrine Mayoux.
In the Paris area, the company Theraclion hosted at Cochin Hospital is working on the scalpel of the future. "Our company is the world's first in its field. We are addressing a public health problem. Our product will help to treat include osteoporosis, a disease that costs 12 to 15 billion euros per year in Europe, which affects 75 million people worldwide, "says Dr. Nujurally Ishmael, Director General Theraclion.The start-up company that employs 10 people including 9 engineers and doctors more graduates tray 5 will be delayed in its projects. "It is incomprehensible to change the rules of the game I am about to commence public offering. Convince private investors will take more time because the payroll will increase, "says Dr. Ishmael Nujurally. I regret that the development of innovative companies is hampered. It is an incentive to go elsewhere if the search becomes too expensive in France. "
Aldebaran Robotics that designs personal robots and employs 100 employees, half of researchers, engineers and university graduate, is studying how to adapt too. "The measures that affect young innovative companies and research tax credit, will have an impact on our cash 500,000 euros from January 1.As the company did not have those 500,000 euros in cash, we must either lower our research efforts is our research relocate to Taiwan where it is cheaper, "says Fabien Bardinet, Deputy Director General of Aldebaran Robotics.
This shift triggers reactions which are stronger than large firms escape the cuts. "Christine Lagarde has taken this week in the Senate defending the research tax credit for large groups. I also hope to hear him say that the economy 54 million provided by the reform of the status of the young innovative company is not justified to 2 billion euros invested annually in research by SMEs, "concludes Philippe Pouletty.